US Patent Issued to Cornell University on May 27 for "Des-acyl ghrelin and analogs as cancer therapies" (New York Inventor)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,311,011, issued on May 27, was assigned to Cornell University (Ithaca, N.Y.).

"Des-acyl ghrelin and analogs as cancer therapies" was invented by Kristy A. Brown (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology relates to methods for treating, preventing, and/or ameliorating cancer comprising administering a therapeutically effective amount of ghrelin, des-acyl ghrelin, or an analog thereof (e.g, the cyclic peptide analog AZP531) to a subject in need thereof. Kits for use in practicing the methods are also provided."

The patent was filed on Sept. 3, 2019, under Application No. 17/271,067.

*For further information, includi...